37例住院患者静脉药物溶媒选择不合理原因分析

Analysis on Unreasonable Selection of Intravenous Drug Solvent in Doctor's Advices of 37 Cases of Hospitalized Patients

目的:分析医院2015年住院患者医嘱中静脉药物溶媒选择不合理的原因。方法:抽取2015年1—12月间静脉药物配制中心(PIVAS)住院患者每月长期医嘱3 000份,共36 000份,分析其溶媒选择不合理的原因。结果:在抽取的36 000份病例中,不合理用药案例119例占0.33%,疑似溶媒选择不合理的案例37例占31.09%;其中中药类注射剂12例,维生素类9例,肝胆疾病用药5例,抗肿瘤药3例和其他8例;按照其说明书和相关文献资料,30例明确判为溶媒选择不合理,另外7例有待进一步研究商榷。结论:输液溶媒合理性的选择必须以药物说明书为主要依据,相关文献资料仅供参考;对疑似溶媒选择不合理案例的分析,有助于促进临床合理选择输液溶媒,保障患者用药安全、有效。

Objective： To analyze the causes of unreasonable selection of intravenous drug solvent in doctor＇s advices of 37 cases of hospitalized patients during the period of 2015. Methods： Extracting 2015 January-December pharmacy intravenous admixture services （PIVAS） of hospital patients（per month of standing orders 3 000 copies and a total of 36 000 of solvent selection） unreasonable reasons were analyzed. Results： in the sample of 36 000 cases, unreasonable medication case of 119 cases（0.33%）, the suspected solvent selection unreasonable cases in 37 cases （31.09%）, including 12 cases of traditional Chinese medicine injections, vitamins in 9 cases, 5 cases of liver and gallbladder disease medication, 3 cases of anti tumor drugs and other 8 cases; according to the specifications and related documents, 30 cases were convicted of irrational selection of solvent and the other 7 cases need further research. Conclusion： The rationality of the choice must be based on solvent infusion medicine instruction that is, it is mainly based on the relevant literature for reference;f or suspected solvent selection, unreasonable case analysis helps to promote the reasonable selection of clinical infusion solvents, to ensure the safety and effective clinical medication.